January 2, 2026 · Form 4 insider transaction
KOZARICH JOHN W sold 21 shares of Ligand Pharmaceuticals Incorporated at $186.59 per share, a transaction worth $3.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.